SYSMEX CORP.UNSP.ADR 1/2 (F:0YX0) — Market Cap & Net Worth
Market Cap & Net Worth: SYSMEX CORP.UNSP.ADR 1/2 (0YX0)
SYSMEX CORP.UNSP.ADR 1/2 (F:0YX0) has a market capitalization of $4.70 Billion (€4.02 Billion) as of October 10, 2026. Listed on the F stock exchange, this Germany-based company holds position #3673 globally and #671 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SYSMEX CORP.UNSP.ADR 1/2's stock price €6.45 by its total outstanding shares 623180031 (623.18 Million).
SYSMEX CORP.UNSP.ADR 1/2 Market Cap History: 2021 to 2026
SYSMEX CORP.UNSP.ADR 1/2's market capitalization history from 2021 to 2026. Data shows change from $27.14 Billion to $6.78 Billion (-31.79% CAGR). Check latest SYSMEX CORP.UNSP.ADR 1/2 stock price today for real-time trading data and today's change.
SYSMEX CORP.UNSP.ADR 1/2 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SYSMEX CORP.UNSP.ADR 1/2's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see SYSMEX CORP.UNSP.ADR 1/2 cash conversion from operations for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.01x
SYSMEX CORP.UNSP.ADR 1/2's market cap is 0.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.10x
SYSMEX CORP.UNSP.ADR 1/2's market cap is 0.10 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $13.28 Billion | $363.78 Billion | $44.09 Billion | 0.04x | 0.30x |
| 2023 | $11.88 Billion | $410.50 Billion | $45.78 Billion | 0.03x | 0.26x |
| 2024 | $12.17 Billion | $461.51 Billion | $49.64 Billion | 0.03x | 0.25x |
| 2025 | $5.39 Billion | $508.64 Billion | $53.67 Billion | 0.01x | 0.10x |
Competitor Companies of 0YX0 by Market Capitalization
Companies near SYSMEX CORP.UNSP.ADR 1/2 in the global market cap rankings as of October 10, 2026. See 0YX0 net asset quality score to understand what proportion of total assets are financed by equity.
Key companies related to SYSMEX CORP.UNSP.ADR 1/2 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #127 globally with a market cap of $173.19 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #235 globally with a market cap of $106.38 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #127 | Abbott Laboratories | NYSE:ABT | $173.19 Billion | $99.60 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $88.48 |
| #235 | Stryker Corporation | NYSE:SYK | $106.38 Billion | $277.33 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
SYSMEX CORP.UNSP.ADR 1/2 Historical Marketcap From 2021 to 2026
Between 2021 and today, SYSMEX CORP.UNSP.ADR 1/2's market cap moved from $27.14 Billion to $ 6.78 Billion, with a yearly change of -31.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €6.78 Billion | +25.68% |
| 2025 | €5.39 Billion | -55.69% |
| 2024 | €12.17 Billion | +2.39% |
| 2023 | €11.88 Billion | -10.51% |
| 2022 | €13.28 Billion | -51.07% |
| 2021 | €27.14 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of SYSMEX CORP.UNSP.ADR 1/2 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.70 Billion USD |
| MoneyControl | $4.70 Billion USD |
| MarketWatch | $4.70 Billion USD |
| marketcap.company | $4.70 Billion USD |
| Reuters | $4.70 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SYSMEX CORP.UNSP.ADR 1/2
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematol… Read more